Yanxia Chen

ORCID: 0000-0002-4590-9408 · 4 papers in corpus
article 2022
Bushen Culuan Decoction Ameliorates Premature Ovarian Insufficiency by Acting on the Nrf2/ARE Signaling Pathway to Alleviate Oxidative Stress
Frontiers in pharmacology ·doi:10.3389/fphar.2022.857932

Premature ovarian insufficiency (POI) can result in lower fertility and shorten the female reproductive span. Bushen-Culuan Decoction (BCD) is a traditional Chinese medication utilized for treating POI for many years. We previously observed…

article 2022
Efficacy of Bushen Culuan decoction on ovarian follicle and follicular granulosa cells in mice with premature ovarian insufficiency induced by tripterygium wilfordii polyglycoside.
·doi:10.19852/j.cnki.jtcm.2022.01.002

OBJECTIVE: To investigate the protective efficacy of Bushen Culuan decoction (BCD) on ovarian follicle and follicular granulosa cells in mice with premature ovarian insufficiency (POI) induced by tripterygium wilfordii polyglycoside, and to…

article 2019
[Clinical experience of Bushen Huoxue therapy in treatment of infertility due to endometriosis].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica ·doi:10.19540/j.cnki.cjcmm.20181225.003

Endometriosis is a common and difficult gynecological disease. The incidence of endometriosis has been increasing year by year. Because endometriosis mostly occurs in childbearing age,it can cause persistent damage to the fertility of patie…

article 2017
Effect of combined therapy GnRH-a plus add-back tibolone on endocrine hormone levels and bone loss in endometriosis patients

Objective: This study is to compare the effect of combined therapy gonadotropin-releasing hormone agonist (GnRH-a) plus add-back tibolone on endocrine hormone levels and bone loss of endometriosis patients. Methods: Totally 100 endometrios…